Biologics & Advanced Therapies

Modern targeted treatments for moderate-severe IBD

Biologics & Advanced TherapiesJul 23, 2026

Anti-Integrin Therapy for IBD: Vedolizumab vs Natalizumab

Vedolizumab vs natalizumab for IBD: compare PML risk, gut selectivity, dosing schedules, onset and trial results before discussing treatment.

Biologics & Advanced TherapiesJul 23, 2026

Anti-TNF Biologics for IBD: How the TNF Blockers Work

Anti-TNF biologics for IBD explained: learn how TNF blockers work and compare 4 drugs, dosing schedules, approved uses, safety risks and screening.

Biologics & Advanced TherapiesOct 2, 2025

Biosimilars & Switching

Switching to biosimilars for IBD: see evidence from 85 publications, learn what interchangeability means, and know what stays the same after a switch.

Biologics & Advanced TherapiesSep 13, 2025

Therapeutic Drug Monitoring (TDM)

Therapeutic drug monitoring for IBD measures biologic trough levels and antibodies. Learn how reactive and proactive TDM guide dosing or switching.